Eagle, Kim A.

Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis

Bhatt, D. L., Eagle, K. A., Ohman, E. M., Hirsch, A. T., Goto, S., Mahoney, E. M., Wilson, P. W. F., Alberts, M. J., D’Agostino, R., Liau, C.-S., et al. (2010) · JAMA

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 753

Characterizing the young patient with aortic dissection: results from the international registry of aortic dissection (IRAD)

Januzzi, J. L., Isselbacher, E. M., Fattori, R., Cooper, J. V., Smith, D. E., Fang, J., Eagle, K. A., Mehta, R. H., Nienaber, C. A., & Pape, L. A. (2004) · Journal of the American College of Cardiology

Aortic Disease and Treatment ApproachesConnective tissue disorders research

Cited by 511

Cocaine-Related Aortic Dissection in Perspective

Eagle, K. A., Isselbacher, E. M., DeSanctis, R. W., & the International Registry for Aortic Dissection (IRAD) Investigators (2002) · Circulation

Aortic Disease and Treatment ApproachesVasculitis and related conditions

Cited by 511

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Cavender, M. A., Steg, P. G., Smith, S. C., Eagle, K., Ohman, E. M., Goto, S., Kuder, J., Im, K., Wilson, P. W. F., & Bhatt, D. L. (2015) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

Cited by 501

β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

Bangalore, S., Steg, G., Deedwania, P., Crowley, K., Eagle, K. A., Goto, S., Ohman, E. M., Cannon, C. P., Smith, S. C., Zeymer, U., et al. (2012) · JAMA

Acute Myocardial Infarction ResearchCardiac Health and Mental Health

Cited by 436

Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry

Kumbhani, D. J., Steg, P. G., Cannon, C. P., Eagle, K. A., Smith, S. C., Goto, S., Ohman, E. M., Elbez, Y., Sritara, P., Baumgartner, I., et al. (2014) · European Heart Journal

Peripheral Artery Disease ManagementLipoproteins and Cardiovascular Health

Cited by 318

ACC/AHA guidelines for ambulatory electrocardiography

Crawford, M. H., Bernstein, S. J., Deedwania, P. C., DiMarco, J. P., Ferrick, K. J., Garson, A., Green, L. A., Greene, H. L., Silka, M. J., Stone, P. H., et al. (1999) · Journal of the American College of Cardiology

ECG Monitoring and AnalysisClinical practice guidelines implementation

Cited by 309

ACC/AHA Guidelines for Ambulatory Electrocardiography: Executive Summary and Recommendations: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) Developed in Collaboration With the North American Society for Pacing and Electrophysiology

Crawford, M. H., Bernstein, S. J., Deedwania, P. C., DiMarco, J. P., Ferrick, K. J., Garson, A., Green, L. A., Greene, H. L., Silka, M. J., Stone, P. H., et al. (1999) · Circulation

ECG Monitoring and AnalysisCardiac pacing and defibrillation studies

Cited by 215

Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database

Hiratzka, L. F., Eagle, K. A., Liang, L., Fonarow, G. C., LaBresh, K. A., & Peterson, E. D. (2007) · Circulation

Coronary Interventions and DiagnosticsClinical practice guidelines implementation

Cited by 75

Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids

Weinberg, R. L., Brook, R. D., Rubenfire, M., & Eagle, K. A. (2021) · Journal of the American College of Cardiology

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 63

Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective

Dumasia, R., Eagle, K., Kline-Rogers, E., May, N., Cho, L., & Mukherjee, D. (2005) · Current Drug Target -Cardiovascular & Hematological Disorders

Peroxisome Proliferator-Activated ReceptorsDiabetes Treatment and Management

Cited by 56

Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Meadows, T. A., Bhatt, D. L., Hirsch, A. T., Creager, M. A., Califf, R. M., Ohman, E. M., Cannon, C. P., Eagle, K. A., Alberts, M. J., Goto, S., et al. (2009) · American Heart Journal

Peripheral Artery Disease ManagementLipoproteins and Cardiovascular Health

Cited by 50